Brief: Enorama Pharma Gets Questions From Swedish Medical Products Agency
Jan 30 (Reuters) - Enorama Pharma AB ERMA.ST :
* ENORAMA PHARMA - HAS RECEIVED QUESTIONS OF "MINOR
CHARACTER"
FROM SWEDISH MEDICAL PRODUCTS AGENCY REGARDING REGISTRATION
APPLICATIONS OF CO'S FOUR NICOTTINE PRODUCTS
Source text for Eikon: ID:nWkr4WmcTW
Further company coverage: ERMA.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO